pentaerythritol

RN given refers to parent cpd; structure in Merck Index, 9th ed, #6904

Also Known As:

Auxitrans; Hydrafuca; pentaerythritol, calcium, zinc salt; pentaerythritol, sodium salt; 2,2-bis(hydroxymethyl)-1,3-propanediol

Networked: 18 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Alcohols: 595
  - Glycols: 38
    - Propylene Glycols: 2
      - pentaerythritol: 18

Experts

1.	Brennecka, Celeste R: 3 articles (11/2013 - 06/2013)
2.	Vernon, Brent L: 3 articles (11/2013 - 06/2013)
3.	Fernández-Mayoralas, Alfonso: 3 articles (01/2007 - 04/2003)
4.	Nieto-Sampedro, Manuel: 3 articles (01/2007 - 04/2003)
5.	Soodak, Kristen F: 2 articles (11/2013 - 06/2013)
6.	Doncel-Pérez, Ernesto: 2 articles (01/2007 - 04/2004)
7.	Li, Sha-Sha: 1 article (01/2022)
8.	Liu, Chao: 1 article (01/2022)
9.	Liu, Zhao-Peng: 1 article (01/2022)
10.	Wu, Jing-De: 1 article (01/2022)

Related Diseases

1.	Aneurysm (Aneurysms) 07/01/2013 - "In this study the authors investigated the use of a liquid-to-solid gelling polymer system-that is, poly(propylene glycol) diacrylate and pentaerythritol tetrakis (3-mercaptopropionate) (PPODA-QT)-to embolize in vivo aneurysms over a 6-month period. " 11/01/2013 - "A liquid-to-solid gelling polymer system, such as the poly(ethylene glycol) diacrylate-pentaerythritol tetrakis (3-mercaptopropionate) (PEGDA-QT) system, can fill cerebral aneurysms more completely than current embolization materials, reducing the likelihood of aneurysm recurrence. " 06/07/2013 - "A liquid-to-solid gelling polymer system, such as the poly(ethylene glycol) diacrylate-pentaerythritol tetrakis (3-mercaptopropionate) (PEGDA-QT) system, can fill cerebral aneurysms more completely than current embolization materials, reducing the likelihood of aneurysm recurrence. "
2.	Constipation 07/01/1983 - "[Controlled study of pentaerythritol in the treatment of subjects with functional intestinal disorders of the constipation type]."
3.	Neoplasms (Cancer) 01/25/2007 - "An N-acetylglucosaminide derivative with a pentaerythritol substituent at position C-6 was previously synthesized and shown to inhibit neural tumor growth. " 04/10/2003 - "An octyl N-acetylglucosaminide derivative with a pentaerythritol chain at position 6 has been synthesized and evaluated as an inhibitor of neural tumor growth. " 09/14/2004 - "The array-designed antisense ODN was covalently conjugated to a novel anionic dendrimer using a pentaerythritol-based phosphoroamidite synthon via automated DNA synthesis and the ability of this conjugate to effectively deliver and down-regulate EGFR expression in cancer cells was evaluated. "
4.	Intracranial Aneurysm (Cerebral Aneurysm) 11/01/2013 - "A liquid-to-solid gelling polymer system, such as the poly(ethylene glycol) diacrylate-pentaerythritol tetrakis (3-mercaptopropionate) (PEGDA-QT) system, can fill cerebral aneurysms more completely than current embolization materials, reducing the likelihood of aneurysm recurrence. " 06/07/2013 - "A liquid-to-solid gelling polymer system, such as the poly(ethylene glycol) diacrylate-pentaerythritol tetrakis (3-mercaptopropionate) (PEGDA-QT) system, can fill cerebral aneurysms more completely than current embolization materials, reducing the likelihood of aneurysm recurrence. "
5.	Stable Angina 08/01/2005 - "Achieved results show that Pentaerythritol compositum can be effective as antianginal drug in patients with stable angina."

Related Drugs and Biologics

1.	Polymers
2.	Propylene Glycol (1,2 Propanediol)
3.	Polyethylene Glycols (Polyethylene Glycol)
4.	poly(ethylene glycol)diacrylate
5.	poly(ethylene glycol) diacrylate-pentaerythritol tetrakis(3-mercaptopropionate)
6.	Proteasome Inhibitors
7.	Dendrimers (Dendrons)
8.	Propranolol (Inderal)
9.	Polyurethanes (Polyurethane)
10.	Peptides (Polypeptides)

Related Therapies and Procedures

1.	Injections